ROMPIETTI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 343
EU - Europa 327
AS - Asia 189
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 863
Nazione #
US - Stati Uniti d'America 342
IT - Italia 141
IE - Irlanda 101
SG - Singapore 75
HK - Hong Kong 53
CN - Cina 31
VN - Vietnam 24
RO - Romania 22
FI - Finlandia 16
DE - Germania 10
UA - Ucraina 8
CZ - Repubblica Ceca 7
RU - Federazione Russa 7
SE - Svezia 5
KR - Corea 4
BE - Belgio 3
CI - Costa d'Avorio 3
CH - Svizzera 2
NL - Olanda 2
AT - Austria 1
CA - Canada 1
EU - Europa 1
FR - Francia 1
GR - Grecia 1
IN - India 1
JP - Giappone 1
Totale 863
Città #
Dublin 101
Chandler 84
Perugia 70
Singapore 58
Hong Kong 53
San Mateo 33
Boardman 32
Dong Ket 24
Bucharest 21
Santa Clara 19
Altamura 13
Beijing 13
Helsinki 13
New York 12
Wilmington 10
Medford 9
Princeton 9
Andover 8
Lawrence 8
Munich 6
Assisi 5
Falls Church 5
Bastia 4
Bologna 4
Brno 4
Collazzone 4
Dearborn 4
Rome 4
Seoul 4
Abidjan 3
Ashburn 3
Brussels 3
Des Moines 3
Foligno 3
Los Angeles 3
Olomouc 3
Amsterdam 2
Ancona 2
Changsha 2
Dallas 2
Moscow 2
Redwood City 2
Saint Petersburg 2
Bhubaneswar 1
Chengdu 1
Civitanova Marche 1
Guangzhou 1
Hanover 1
Hefei 1
Lappeenranta 1
Ludwigshafen 1
Montréal 1
Nanjing 1
Quattro Castella 1
Redmond 1
San Paolo di Civitate 1
Sector 6 1
Shenzhen 1
Tokyo 1
Vienna 1
Totale 686
Nome #
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 131
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 71
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 71
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 71
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia 69
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 69
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 67
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 61
Blockade of Oncogenic NOTCH1 With the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 57
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 40
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia 37
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 32
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 30
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL 25
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 24
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 22
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia 18
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential 17
Totale 912
Categoria #
all - tutte 5.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 4 0 5 4 26 2 0
2020/202168 2 6 0 1 18 2 0 3 3 1 8 24
2021/2022163 2 31 1 0 4 3 1 23 2 30 29 37
2022/2023290 9 39 1 27 30 20 11 21 116 0 11 5
2023/2024185 6 14 10 9 0 7 67 1 11 4 21 35
2024/2025124 22 33 16 21 32 0 0 0 0 0 0 0
Totale 912